l to check sample integrity prior to subsequent analysis. Vacuum Technology: The company’s vacuum technologies products are used to create, control, measure and test vacuum environments in life science, industrial and scientific applications where ultra-clean, high-vacuum environments are needed. Vacuum technologies' customers are typically OEMs that manufacture equipment for these applications. Products include a range of vacuum pumps (diffusion, turbomolecular and ion getter), intermediate vacuum pumps (rotary vane, sorption and dry scroll), vacuum instrumentation (vacuum control instruments, sensor gauges and meters) and vacuum components (valves, flanges and other mechanical hardware). These products also include helium MS and helium-sensing leak detection instruments used to identify and measure leaks in hermetic or vacuum environments. In addition to product sales, the company offers a range of services, including an exchange and rebuild program, assistance with the design and integration of vacuum systems, applications support and training in basic and advanced vacuum technologies. Life Sciences and Applied Markets Customers The company had approximately 23,000 customers for its life sciences and applied markets business in fiscal 2015. A significant number of the company’s life sciences and applied markets customers are also customers of its Agilent CrossLab business. Life Sciences and Applied Markets Sales, Marketing and Support The company primarily uses direct sales to market its solutions to its pharmaceutical, biopharmaceutical and clinical accounts. The company’s active reseller program augments its ability to provide solutions to its customers. The company sells its consumable products through distributors, electronic commerce and direct sales. Life Sciences and Applied Markets Manufacturing The company’s manufacturing supports its diverse product range and customer-centric focus. The company assembles highly configurable products to individual customer orders and makes standard products to stock. The company selectively uses third parties to provide some supply chain processes for manufacturing, warehousing and logistics. The company has a Food and Drug Administration (FDA) registered site in California, Germany, and Singapore. Life Sciences and Applied Markets Competition The company’s principal competitors in the life sciences and applied markets arena include Danaher Corporation; Thermo Fisher Scientific Inc.; Waters Corp.; and Shimadzu Corp. Diagnostics and Genomics Business The company’s diagnostics and genomics business includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid contract manufacturing businesses. Its diagnostics and genomics business is comprised of three areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, the company’s pathology solutions business is focused on product offerings to cancer diagnostics and anatomic pathology workflows. The portfolio of offerings includes immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin staining and special staining. The company also collaborates with various major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Second, the company’s genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as Next Generation Sequencing target enrichment. Finally, the company’s nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices (GMP) conditions for use as active pharmaceutical ingredients (API) in an emerging class of drugs that utilize nucleic acid molecules for disease
agilent technologies inc (AG8:Frankfurt)
5301 Stevens Creek Boulevard
Santa Clara, CA 95051
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for AG8.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact AGILENT TECHNOLOGIES INC, please visit www.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.